• Latest Posts

The Best Selling Biologic of All Time now chased by New Phase III Biosimilar

Biotech of the week: Solvo, an Efficient Drug Transportation Solution in Hungary

Why is J&J getting rid of Galapagos’ shares, when Everyone else is Buying?

This Leading Israeli Biopharma is in Good Shape to fight Crohn’s Disease

Reviewing Autism: Can Biotech open up New Horizons?


Swiss Cancer Vaccine Gets 2 FDA Orphan Drug Designations

New Joint Venture to Shake Up Immuno-Oncology in the UK

Chinese Chemical Giant moves closer to buy Swiss Syngenta for €39.5Bn

Artificial Hearts are one Step Closer to the Market with €50M in Funding

French Ipsen closes €700M deal for Californian Cancer Drug

Overcoming the Challenges of Text-Mining in Biotech Research